Refine Your Pitch Strategy, Sharpen Your Positioning to Investors, & Understand Expectations for Deal Conversations

Whether developing first-in-class degraders, best-in-class TCEs, novel payloads for ADCs, or AI-driven drug discovery platforms to validate new targets, the clinical and competitive challenges in today's landscape demand collaboration with pharma to validate technology, access capital, and leverage infrastructure to achieve Phase 3 success.

Bringing independent Autoimmunity, ADC, TPD, and TCE Partnering Summits into a single arena, the Oncology & Immunology Innovation Partnering & Licensing Summit gathers a critical mass of related discovery technologies and development pipelines.

Gain an Insight into:

  • Which stage of development, in detail, are pharma and investors looking for?
  • What data is valuable for pharma to see when not in the clinic?
  • What is a key element of differentiation that a biotech can demonstrate?
  • How much opportunity is there for novel targets?
  • Which targets will be most important in 10 years’ time?

Through a dedicated one-to-one partnering system, organized matchmaking, and total audience alignment, pharma can efficiently meet, provide feedback on, and compare licensing and co-development opportunities, whilst biotech business development can cut through the noise and competition to secure guaranteed meetings with key stakeholders.

Speakers at Oncology & Immunology Innovation Partnering

Explore the Full Event Guide

  • A 1-to-5 ratio of biotech to pharma & investors guarantees you face-to-face time with top prospects
  • One-to-One Partnering with the right decision-makers to drive feedback, validation & partnerships
  • Pharma & investors present in >40% of meetings
  • Two formal structured networking sessions, one informal drinks reception
  • Refine your strategy, strengthen your pitch, nurture your relationships to stay front-of-mind after BIO & before JPM
71308 - Oncology & Immunology Innovation Partnering Brochure Image (2)

Attending Companies Include

Audience at Oncology & Immunology Innovation Partnering

Review the Program

Determine whether this highly targeted partnering event can help accelerate your partnering objectives. Explore the event format, expert speaker faculty, and remaining presentation opportunities to see how you can connect with the right decision-makers and maximise your time onsite.
Networking at Oncology & Immunology Innovation Partnering

Elevate Your Brand

Position your brand at the centre of deal-making and gain near-exclusive visibility among senior biotech, pharma, and investment leaders actively seeking new opportunities. Ideal for law firms, banks, CROs, CDMOs, and omics providers looking to strengthen brand recognition through meaningful, high-value interactions.
Speaker at Oncology & Immunology Innovation Partnering

Register to Join

Connect with innovators, investors, and strategic partners at a uniquely timed event designed to bridge the gap between BIO and JPM. Take advantage of early-bird savings, elevate your profile with a presentation slot, and increase your visibility by showcasing your company logo on the event website ahead of the meeting.